These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9177233)

  • 1. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
    Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
    Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
    World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
    Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
    Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
    O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
    J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
    J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.
    Asanuma K; Tsuji N; Endoh T; Yagihashi A; Watanabe N
    J Immunol; 2004 Mar; 172(6):3922-9. PubMed ID: 15004200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
    O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
    Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
    Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
    J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
    Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
    Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system.
    Zhu Q; Liu JY; Xu HW; Yang CM; Zhang AZ; Cui Y; Wang HB
    World J Gastroenterol; 2005 Oct; 11(39):6125-9. PubMed ID: 16273638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
    Xu T; Sun BC; Li Q; Hao XS
    World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
    Uzzo RG; Rayman P; Kolenko V; Clark PE; Bloom T; Ward AM; Molto L; Tannenbaum C; Worford LJ; Bukowski R; Tubbs R; Hsi ED; Bander NH; Novick AC; Finke JH
    Clin Cancer Res; 1999 May; 5(5):1219-29. PubMed ID: 10353760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
    Ueyama H; Kiyohara T; Sawada N; Isozaki K; Kitamura S; Kondo S; Miyagawa J; Kanayama S; Shinomura Y; Ishikawa H; Ohtani T; Nezu R; Nagata S; Matsuzawa Y
    Gut; 1998 Jul; 43(1):48-55. PubMed ID: 9771405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
    Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
    Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human colon cancer cells express the functional Fas ligand.
    Ding EX; Hizuta A; Morimoto Y; Tanida T; Hongo T; Ishii T; Yamano T; Fujiwara T; Iwagaki H; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):13-24. PubMed ID: 9755840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of Fas and Fas ligand on human intestinal intraepithelial lymphocytes.
    Morimoto Y; Hizuta A; Ding EX; Ishii T; Hongo T; Fujiwara T; Iwagaki H; Tanaka N
    Clin Exp Immunol; 1999 Apr; 116(1):84-9. PubMed ID: 10209509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.